Our Solutions
Duraent prioritizes customer satisfaction by listening to their needs, tailoring products and services accordingly, and exceeding expectations through a customer-centric approach
Immunobiogram
Revolutionizing kidney transplant care with a blood-based test, personalising immunosuppressive therapy for each patient, ensuring precision and better outcomes.
OmniGraf
The first non-invasive blood test that empowers clinicians to confidently rule out subclinical acute rejection and ensure optimal immune system management in liver transplant patients.
Trugraf Kidney
First non-invasive blood test to rule out subclinical acute rejection (subAR) during Stable Renal Function.
TRAC
Firstnon-invasive blood test to rule out clinical acute rejection in Renal Dysfunction.
TRAC ID
Non-invasive means to monitor the risk of graft rejection and infection in kidney transplant recipients.
